http://www.laboratorytalk.com/news/nim/nim000.html Roche Nimblegen news releases on Laboratorytalk en-gb Copyright (C)2008 Pro-Talk Ltd. All rights reserved. Wed, 18 Jun 2008 08:00:00 UT Wed, 18 Jun 2008 08:00:00 UT http://www.pro-talk.com/images/protalklogo90.gif http://www.pro-talk.com/ 90 79 Roche NimbleGen has formed a strategic alliance with BioDiscovery to offer complete solutions to comparative genomic hybridization (CGH) microarray customers Thu, 05 Jun 2008 08:00:00 UT Roche Nimblegen http://www.laboratorytalk.com/news/nim/nim111.html Roche NimbleGen has announced the commercial launch of its NimbleGen Sequence Capture technology for scientists interested in selecting targeted regions of the genome for high-throughput sequencing Tue, 08 Apr 2008 08:00:00 UT Roche Nimblegen http://www.laboratorytalk.com/news/nim/nim110.html Roche NimbleGen, a company of Roche Applied Science, and Affymetrix have expanded the terms of the license to a number of Affymetrix patents originally granted in October 2006 Mon, 17 Mar 2008 08:00:00 UT Roche Nimblegen http://www.laboratorytalk.com/news/nim/nim109.html Researchers at the University of Washington and the Howard Hughes Medical Institute have discovered several new genetic causes of mental retardation, according to a study published in Nature Genetics Tue, 15 Aug 2006 08:00:00 UT Roche Nimblegen http://www.laboratorytalk.com/news/nim/nim108.html NimbleGen Systems, a supplier of flexible, high-density DNA microarrays used in the fastest growing markets for genome research, has named David S Snyder as chief financial officer Wed, 09 Aug 2006 08:00:00 UT Roche Nimblegen http://www.laboratorytalk.com/news/nim/nim107.html A number of limited access partners have been selected to work with the company's second-generation NimbleChip HD2 microarrays, each containing more than 2 million probes. Wed, 26 Jul 2006 08:00:00 UT Roche Nimblegen http://www.laboratorytalk.com/news/nim/nim106.html Splice variant microarrays have the potential to replace gene expression arrays for clinical markers, diagnostics, and target validation research due to greater specificity and biological relevance Mon, 06 Feb 2006 08:00:00 UT Roche Nimblegen http://www.laboratorytalk.com/news/nim/nim105.html Scientists from the National Institute of Allergy and Infectious Diseases (NIAID) have determined how a promising drug candidate attacks the bacterium that causes tuberculosis (TB) Thu, 05 Jan 2006 08:00:00 UT Roche Nimblegen http://www.laboratorytalk.com/news/nim/nim104.html Researchers at the University of Chicago and the Wellcome Trust Sanger Institute have determined that small deletions in the human genome occur in a much greater number than previously assumed Fri, 16 Dec 2005 08:00:00 UT Roche Nimblegen http://www.laboratorytalk.com/news/nim/nim103.html Provider of flexible high-density microarray products and services for a number of emerging applications in genetic analysis, has raised a total of $50 million since its inception in 1999 Tue, 06 Dec 2005 08:00:00 UT Roche Nimblegen http://www.laboratorytalk.com/news/nim/nim102.html NimbleGen Systems has announced the closing of its series D financing in the amount of $12.5 million; it has now raised $32.5 million altogether Thu, 24 Apr 2003 08:00:00 UT Roche Nimblegen http://www.laboratorytalk.com/news/nim/nim101.html Appointment of exclusive distributor in Japan is part of strategy to serve functional genomics research throughout the Asia-Pacific region Mon, 21 Apr 2003 08:00:00 UT Roche Nimblegen http://www.laboratorytalk.com/news/nim/nim100.html